CBLLCeriBell, Inc.
$27.15+103% 1Y
$27.15
$10.9252 weeks$27.69
Is the price fair?
What CBLL's price assumes
CeriBell, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 7.25× revenue.
7.25
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 5.76
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 5.76
- EV / EBIToperating margin −69%: the multiple describes the denominator
- not meaningful
- Market capitalisation38.4 million shares, counted Aug 6, 2026
- $1.04B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
The closest names by size in the same industry